Loading clinical trials...
Loading clinical trials...
Individualized Multiplex Pathophysiological Treatment of Severe Acute Infections (IMPACT): A Randomized, Open-Label Clinical Trial to Assess Whether an Individualized Treatment Strategy Aimed at Preventing Organ Dysfunction Can Reduce Mortality and Decrease Hospital Length of Stay in Patients With Severe Acute Infections
Conditions
Interventions
Individualized Treatment Strategy
Locations
1
Denmark
Department of Emergency Medicine, Copenhagen University Hospital - Bispebjerg and Frederiksberg
Copenhagen, Denmark
Start Date
February 1, 2026
Primary Completion Date
September 1, 2027
Completion Date
February 1, 2028
Last Updated
December 9, 2025
NCT04850456
NCT04955210
NCT07179276
NCT05267821
NCT07448805
NCT07351344
Lead Sponsor
Theis S. Itenov
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions